ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive: Moreover, there are no reports concerning the combination of BCR-ABL1IS and the BCR-ABL1 halving time at 3 months for EMR evaluation, especially for the CML-CP patients with BCR-ABL1IS >10%.